• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Aspira Share Price

    Aspira Pathlab & Diagnostics Share PriceAspira Pathlab & Diagnostics

    Small Cap 1.9k Result
    ₹34.95
    -0.2 (-0.57%)
    As on 04 October, 2023 | 22:47 BSE: 540788 NSE: ASPIRAISIN: INE500C01017

    Aspira Pathlab & Diagnostics Performance

    Day Range

    • Low
    • High
    34.95

    52 Week Range

    • Low
    • High
    34.95
    • Open Price
    • Previous Close
    • Volume

    Start SIP in Aspira Pathlab & Diagnostics

    Start SIP

    Aspira Pathlab & Diagnostics Share Price

    • Over 1 Month -10.08%
    • Over 3 Month 23.06%
    • Over 6 Month 18.03%
    • Over 1 Year -20.57%

    Aspira Pathlab & Diagnostics Key Statistics

    Aspira Pathlab & Diagnostics Investment Rating

    • Master Rating:

    • Aspira Pathlab & Diag has an operating revenue of Rs. 14.09 Cr. on a trailing 12-month basis. An annual revenue de-growth of -25% needs improvement, Pre-tax margin of -1% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 8%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 4 which is a POOR score indicating inconsistency in earnings, a RS Rating of 35 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 81 indicates it belongs to a poor industry group of Medical-Services and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Aspira Pathlab & Diagnostics Financials
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 334435
    Operating Expenses Qtr Cr 334333
    Operating Profit Qtr Cr 001002
    Depreciation Qtr Cr 000001
    Interest Qtr Cr 000000
    Tax Qtr Cr 000000
    Net Profit Qtr Cr -100001
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1520
    Operating Expenses Annual Cr 1313
    Operating Profit Annual in Cr 26
    Depreciation Cr 22
    Interest Annual Cr 00
    Tax Annual Cr 00
    Net Profit Annual Cr 04
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 2
    Cash from Investing Activity Annual Cr -1
    Cash from Financing Annual Activity Cr -1
    Net Cash Flow Annual Cr 0
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 138
    Fixed Assets Annual Cr 810
    Total Non Current Assets Annual Cr 1111
    Total Current Assets Annual Cr 67
    Total Assets Annual Cr 1718
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 128
    ROE Annual % -157
    ROCE Annual % 230
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1333
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %

    Aspira Pathlab & Diagnostics Technicals

    EMA & SMA

    Current Price
    ₹34.95
    -0.2 (-0.57%)
    pointer
    • Bullish Moving Average
    • ___
    • 8
    • Bearish Moving Average
    • ___
    • 8
    • 20 Day
    • ₹35.27
    • 50 Day
    • ₹34.11
    • 100 Day
    • ₹33.32
    • 200 Day
    • ₹35.43
    • 20 Day
    • ₹35.63
    • 50 Day
    • ₹33.44
    • 100 Day
    • ₹31.43
    • 200 Day
    • ₹34.16

    Aspira Pathlab & Diagnostics Resistance and Support

    PIVOT
    ₹34.45
    Resistance
    First Resistance ₹35.5
    Second Resistance ₹36.04
    Third Resistance ₹37.09
    RSI 49.31
    MFI 58.06
    MACD Single Line 0.17
    MACD -0.08
    Support
    First Resistance ₹33.91
    Second Resistance ₹32.86
    Third Resistance ₹32.32

    Aspira Pathlab & Diagnostics Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 572 57,200 100
    Week 619 61,875 100
    1 Month 972 97,150 100
    6 Month 4,295 326,139 75.94

    Aspira Pathlab & Diagnostics Result Highlights

    Aspira Pathlab & Diagnostics Synopsis

    BSE-Medical-Services

    Aspira Pathlab & Dia is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 14.46 Cr. and Equity Capital is Rs. 10.29 Cr. for the Year ended 31/03/2023. Aspira Pathlab & Diagnostics Ltd. is a Public Limited Listed company incorporated on 03/07/1973 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85100MH1973PLC289209 and registration number is 289209.
    Market Cap 36
    Sales 14
    Shares in Float 0.83
    No of funds
    Yield
    Book Value 2.82
    U/D Vol ratio 1.8
    LTDebt / Equity 8
    Alpha 0.06
    Beta -0.48

    Aspira Pathlab & Diagnostics

    Owner NameJun-23Mar-23Dec-22
    Promoters 19.37%19.47%19.48%
    Individual Investors 51.76%51.49%52.61%
    Others 28.87%29.04%27.91%

    Aspira Pathlab & Diagnostics Management

    Name Designation
    Dr. Haseeb Drabu Chairman & Ind.Director
    Dr. Pankaj J Shah Managing Director & CEO
    Mr. Arvind Karsandas Bhanushali Executive Director
    Mr. Nikunj Mange Executive Director
    Dr. Subhash Raghunath Salunke Independent Director
    Mrs. Mangala K Prabhu Independent Director
    Mr. Avinash C Mahajan Independent Director

    Aspira Pathlab & Diagnostics Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Aspira Pathlab & Diagnostics Corporate Action

    Date Purpose Remarks
    2023-08-12 Quarterly Results
    2023-05-27 Audited Results
    2023-02-14 Quarterly Results
    2022-11-12 Quarterly Results
    2022-08-13 Quarterly Results & A.G.M.
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    Aspira Pathlab & Diagnostics FAQs

    What is Share Price of Aspira Pathlab & Diagnostics ?

    Aspira Pathlab & Diagnostics share price is ₹34 As on 04 October, 2023 | 22:33

    What is the Market Cap of Aspira Pathlab & Diagnostics ?

    The Market Cap of Aspira Pathlab & Diagnostics is ₹36 Cr As on 04 October, 2023 | 22:33

    What is the P/E ratio of Aspira Pathlab & Diagnostics ?

    The P/E ratio of Aspira Pathlab & Diagnostics is -69.3 As on 04 October, 2023 | 22:33

    What is the PB ratio of Aspira Pathlab & Diagnostics ?

    The PB ratio of Aspira Pathlab & Diagnostics is 2.8 As on 04 October, 2023 | 22:33

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.